Coeur Mining (CDE) buy thesis after a 25% pullback: record results, New Gold integration boosts 2026 EBITDA/FCF, fair value ...

Clarion Partners Real Estate Income Fund completed five equity acquisitions in Q4 2025 while maintaining distributions. Read ...

Carl Icahn’s Q4 2025 13F portfolio remains concentrated in Icahn Enterprises, CVR Energy, Southwest Gas, CVR Partners, and ...

Despite posting its second consecutive positive EPS, Rubrik shares are pressured by negative AI displacement sentiment. Read ...

U.S. oil CEOs warn Hormuz disruptions could spike crude and fuel shortages; Trump weighs reserves and sanctions relief.

Oil prices jump as the Iran war disrupts Strait of Hormuz shipping; Brent/WTI hit 2022 highs as IEA releases reserves.

One of President Donald Trump’s main goals in the war involving Iran is to prevent the country from ever developing nuclear ...

The S&P500 has now dropped over 5% from the high, but it has been a slow and ponderous route, taking 31 sessions. Corrections ...

Two high-yield assets offer inflation protection and income while thriving in an AI economy with growth for early retirees.

PGIM Jennison Health Sciences Fund outperformed its index in Q4 2025, led by Eli Lilly and Arcutis. Read the full analysis for more details.

BCB Bancorp (BCBP) stock stays a Hold despite a deep book-value discount as losses, charge-offs and weak efficiency persist.

Cresco Labs (OTCQX: CRLBF) reported weak Q4-2025 financial results with decreasing revenue and a high net loss. Q1 outlook is also weak since the company has discontinued its California operations. On ...